Aldosterone-producing adenoma (APA) and bilateral adrenal hyperplasia are the major causes of sporadic PA. 6 It is of value to detect the molecular mechanisms of APA, a possibly curable disease, because adrenalectomy could partially reverse hypertension and cardiovascular damage. 8 In 2011, Choi et al identified 2 somatic mutations (G151R, L168R) in the KCNJ5 gene (encoding a potassium inwardly rectifying channel) in 8 out of 22 sporadic APAs. 9 The authors explained that KCNJ5 mutations resulted in a loss of K + channel selectivity and constitutive aldosterone production. This discovery has provided new insight into the molecular mechanisms of APA pathogenesis. More recently, somatic mutations in 3 other genes, namely, ATP1A1 (encoding the α1 subunit of the Na + /K + -ATPase), ATP2B3 (encoding the plasma membrane Ca 2+ -ATPase 3), and CACNA1D (encoding the Ca V 1.3 channel), were revealed to increase aldosterone biosynthesis in APAs. [10] [11] [12] Mutations of these genes could affect adrenal zona glomerulosa cell membrane potential and intracellular ionic homeostasis.
As these acquired mutations were only detected in resected APAs, the clinical implications of somatic mutations remain to be determined. Intriguingly, recent observations showed that KCNJ5 mutation carriers might exhibit a more florid phenotype with younger age, 13, 14 higher aldosterone level, 13, 14 and prominent cardiac damage. 15 Currently, there has not been agreement on the correlation between KCNJ5 mutations and response to adrenalectomy. 15, 16 Therefore, a greater number of cases need to be studied to evaluate the clinical characteristics of patients with and without somatic mutations in APAs. There has been no study investigating somatic mutations in APAs in China thus far. In this study, we explored KCNJ5, ATP1A1, ATP2B3, and CACNA1D for mutations in 168 consecutive Chinese patients with sporadic APA and investigated the clinical and biochemical characteristics associated with somatic mutations.
Methods
An expanded Methods section is available in the online-only Data Supplement.
Subjects and Diagnostic Criteria
One hundred sixty-eight cases with APA (83 males and 85 females) were consecutively enrolled in the study from 2008 to 2014. All cases were hospitalized in the Department of Hypertension for diagnosis and then underwent adrenalectomy in the Department of Urology (Ruijin Hospital, Shanghai Jiao Tong University School of Medicine). The diagnostic process of APA was formulated accordingly based on the recommendations of current guidelines ( Figure S1 in the onlineonly Data Supplement). 6, 17 All subjects provided written informed consent, and the procedure got approval of the local ethics committee. The detailed procedure is shown in the online-only Data Supplement.
Sequencing of the KCNJ5, ATP1A1, ATP2B3, and CACNA1D Genes
Detailed data for DNA extraction and Sanger Sequencing are available in the online-only Data Supplement.
Western Blotting
Western blotting was performed to detect KCNJ5 protein expression in 50 APAs. Relative protein quantification was evaluated by Image J 1.44 (National Institutes of Health, Bethesda, MD).
Biophysical Properties of the KCNJ5

T148-T149insR
Mutation in Vitro
Adrenocortical carcinoma NCI-H295R cells or human embryonic kidney 293T cells were transiently transfected with KCNJ5 T148-T149insR (or KCNJ5
WT as control) and KCNJ3. The mRNA expression of CYP11B2 (aldosterone synthase gene) was assessed, and the supernatant was collected for aldosterone measurement. In addition, whole-cell voltage clamp recordings were performed.
Statistical Analysis
Statistical analyses were performed using the SPSS Statistics 19.0. Categorical variables were compared with chi-square test. Normally distributed continuous variables were presented as mean±SD and analyzed using Student's t test or 1-way ANOVA. Skewed variables were presented as median (25th-75th percentile), which underwent logarithmic or square transformation before Student's t test. If not appropriate, skewed variables were analyzed using Mann-Whitney U test. P<0.05 was considered as statistically significant.
Results
KCNJ5 Sequencing and Identification of a New KCNJ5 Mutation
Somatic KCNJ5 mutations were screened in 129 (76.8%) of the 168 APAs (Table 1) . In these 129 cases, no KCNJ5 mutation was found in the normal adrenal tissue (n=116) or peripheral blood (n=87). The KCNJ5 mutations included G151R, L168R, and T158A mutations in 67, 60, and 1 case(s), respectively, and a novel insertion mutation (c.445-446insGAA, p.T148-T149insR) in a patient ( Figure 1A ). Of the 67 cases with recurrent G151R, 41 carried c.451G>A, and the remaining 26 carried c.451G>C. In addition, homology alignments of the protein sequences showed that all 4 identified mutations are highly conserved among most species ( Figure S2A ).
No somatic mutation was found in the KCNJ5 gene in 11 cortisol-producing adenomas, 10 adrenal pheochromocytomas, or 26 nonfunctional adrenal adenomas.
Sequencing of the ATP1A1, ATP2B3, and CACNA1D Genes
In the 39 cases without KCNJ5 mutations, 6 cases were found with somatic mutations in ATP1A1 (n=4, male), ATP2B3 (n=1, male), or CACNA1D (n=1, female; Table 2 ). These included a known ATP1A1 mutation (L104R, 3 cases) and a known CACNA1D mutation (G403R, 1 case), as well as a new ATP1A1 variant (c.304-309delATGTTA, p.M102-L103del; Figure 1B ) and a new ATP2B3 variant (c.1264-1278delGTCACTGT-GCTGGTCinsAGCACACTC, p.delV422-V426insSTL; Figure 1C ). Of these, the ATP1A1 variants and the ATP2B3 variant were highly conserved in most species ( Figures S2B  and S2C ). None of these mutations were found in the normal adjacent adrenal tissue (n=6) and peripheral blood (n=3). Carriers and noncarriers of the KCNJ5 mutations were similar in age at operation, duration of hypertension, baseline systolic blood pressure, diastolic blood pressure, plasma aldosterone concentration, urinary protein excretion, glomerular filtration rate, and left ventricle mass index (P≥0.075; Table 3 ). Nonetheless, carriers of the somatic KCNJ5 mutations, compared with noncarriers, had a higher proportion of women (56.6% versus 33.3%; P=0.02), larger tumor size (P=0.02), higher urinary aldosterone excretion (P=0.038), and aldosterone-renin ratio (P=0.007), greater lateralization index (P=0.052), and lower plasma renin activity (P=0.018), and minimal serum K + level (P=0.022). After adjustment for sex and age, all differences remained significant (P≤0.053; Table 3 ).
The patient harboring the novel KCNJ5 T148-T149insR mutation was a 62-year-old female and had hypertension for >20 years. Systolic/diastolic blood pressures were 160/90 mm Hg under 3 antihypertensive drugs. The minimal serum K + concentration was 2.1 mmol/L and aldosterone-renin ratio was 95 (ng/ dL)/(ng/mL/h). A right adrenal mass (20 mm in diameter) showed aldosterone hypersecretion (lateralization index=5.6).
KCNJ5 Protein Expression in APAs
We performed western blotting in 31 APAs with KCNJ5 mutations and 19 APAs without the KCNJ5 mutations to investigate whether mutant KCNJ5 was associated with altered expression of KCNJ5 protein. We did not find significant change of the KCNJ5 protein expression in APAs with mutant KCNJ5 (P=0.207; Figure 2 ).
Biophysical Properties of the KCNJ5
T148-T149insR
Mutation in Vitro
We investigated the effect of the insertion mutation T148-T149insR in KCNJ5 on aldosterone expression by transiently cotransfecting KCNJ3 with mutant or wild-type KCNJ5 in H295R cells. At 48 hours after electroporation, T148-T149insR, compared with wild type and empty vector, could stimulate CYP11B2 mRNA upregulation by 9.8-fold (P<0.001) and 7.2-fold (P<0.001; Figure 3A ), respectively. After adjustment for total protein, H295R cells expressing T148-T149insR released more aldosterone to the supernatant, 5.4-fold (P<0.001) and 5.0-fold (P<0.001) higher than cells expressing wild-type and empty vector ( Figure 3B ), respectively.
We further explored the underlying mechanism for the T148-T149insR mutation causing increased aldosterone production. We coexpressed KCNJ3 with mutant or wild-type KCNJ5 in 293T cells and recorded currents at voltages ranging from −100 mV to +60 mV by whole-cell recordings with physiological solutions and extracellular Na + free solutions ( Figure 4 ). KCNJ3/KCNJ5
WT induced an inwardly rectifying current with a reversal potential of −23±3 mV. This current was remarkably decreased in the presence of BaCl 2 by 90.4% at −100 mV, which was used to test the K + channel sensitivity to barium. In contrast, KCNJ3/KCNJ5 T148-T149insR produced a current which was only partially blocked in the presence of BaCl 2 by 28.3% at −100 mV. In addition, this mutant channel exhibited membrane depolarization with a less negative reversal potential (−3±1 mV). The substitution of choline for extracelluar Na + markedly inhibited the currents of the mutant channel with a hyperpolarized potential (−23±2 mV).
We also studied the effect of KCNJ5 T148-T149insR on intracellular Ca 2+ homeostasis in cotransfected H295R cells with KCNJ3 and mutant KCNJ5 or wild-type KCNJ5. The intracellular Ca 2+ concentration as assessed by the Fura-2/AM ratio was higher in KCNJ3/KCNJ5
T148-T149insR cells than in KCNJ3/ KCNJ5
WT and empty vector cells both by 1.2-fold (P<0.01; Figure S3 ).
Discussion
Our study is the first to report somatic mutations in the KCNJ5 gene and several other genes in Chinese patients with APA. Indeed, 76.8% of the Chinese APAs had somatic KCNJ5 mutations, and in the absence of the KCNJ5 mutations, some, though not many, had somatic mutations in the ATP1A1, ATP2B3, and CACNA1D genes. Our observation on the remarkably high proportion of KCNJ5 mutations is in line with the result of a Japanese study where the prevalence was 65.2% in 23 Japanese APAs.
14 In a review study across populations, the total prevalence of somatic KCNJ5 mutations in APAs was ≈40%.
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Our observations on the characteristics of patients with somatic KCNJ5 mutations are also in accordance with the results of several other studies in different populations in several aspects. 10, 13, 14, [18] [19] [20] [21] [22] First, somatic KCNJ5 mutations were more common in female than male patients. Second, in the presence of KCNJ5 mutations, larger tumor size, higher urinary aldosterone, higher aldosterone-renin ratio, and lateralization index were observed, which suggested that excess aldosterone was related to the mutated APA. The patients with KCNJ5 mutations were more likely to be diagnosed Figure 2 . Effect of KCNJ5 mutations on KCNJ5 protein expression in aldosterone-producing adenomas (APAs). KCNJ5 protein expression in APAs carrying wild-type KCNJ5 (n=19) and mutant KCNJ5 (n=31) was evaluated by western blotting. Data were presented as median (25th-75th percentile) and analyzed using Mann-Whitney U test. and receive adrenalectomy. Third, in the presence of KCNJ5 mutations, the minimal K + concentration was lower. Because severe hypokalemia was a major indicator of PA, the patients with KCNJ5 mutations were therefore more likely to be screened for PA. These characteristics of patients with KCNJ5 mutations suggest that identification of the mutations may have prognostic significance.
In our study, the KCNJ5 mutations did not affect the expression of the protein. This finding is in agreement with the result of a previous report. 20 We further investigated the function of the novel somatic KCNJ5 mutation (T148-T149insR). Our findings indicate that this mutation is capable of increasing aldosterone production, as several previously identified mutations (W126R, 23 G151R, 23 T158A, 24 and Ins T149 25 ). The patient harboring this mutation was also resistant to drug treatment as described in another report. 25 Of note, using the active heterotetramers of KCNJ3/KCNJ5, 26 we observed that CYP11B2 mRNA expression was upregulated by 9.8-fold and aldosterone concentration by 5.4-fold in KCNJ3/KCNJ5 T148-T149insR expressing cells, compared with KCNJ3/KCNJ5 wild type . We therefore conclude that this mutation may also stimulate aldosterone biosynthesis.
The underlying mechanisms for the relationship between T148-T149insR in KCNJ5 and aldosterone biosynthesis remain incompletely understood. This novel mutation is positioned closely to the K + channel selectivity filter and is highly conserved among disparate species. It is clear that the T148-T149insR mutation caused a loss of K + ion selectivity and a less negative reversal potential, which might be accompanied with a pathological Na + permeability similarly as the mutations at G151. 9, 27, 28 Other somatic mutations (G151R, 9 L168R, 9 del I157, 29 and Ins T149 25 ) in KCNJ5 also had the similar electrophysiological feature. Membrane depolarization in the adrenal zona glomerulosa cells could increase intracellular Ca 2+ concentration through activation of voltage-gated Ca 2+ channels and Na + /Ca 2+ exchangers, which led to aldosterone biosynthesis eventually. 25 Our finding on the mutations of ATP1A1 and ATP2B3 is also consistent with the results of a recent study in 2 aspects. 10 First, KCNJ5 and ATP1A1 or ATP2B3 mutations were not concomitantly observed. Second, ATPase alterations showed male dominance.
Limitations
This work was conducted in a single center and not representative of the whole APAs. The prevalence of somatic KCNJ5 mutations is not so high in another Asian population. 30 International multicenter studies may help reduce selection bias. In addition, long-term follow-up has not been accomplished, and we are unable to predict prognosis based on KCNJ5 mutations at present.
In summary, we investigated the prevalence of KCNJ5, ATP1A1, ATP2B3, and CACNA1D mutations in the Chinese patients with sporadic APA. Patients with the KCNJ5 mutations had clearly distinguishable phenotypes. The T148-T149insR mutation in KCNJ5 might influence K + channel selectivity and autonomous aldosterone production. 
Perspectives
The trigger for the occurrence of somatic mutations in APAs would be an interesting research theme. As there is currently no definite correlation between somatic KCNJ5 mutations and nodule formation, 31 further investigation on this aspect is needed. In addition, easily accessible biomarkers of APAs should be explored in other possible biological samples.
• We found a novel insertion mutation (c.445-446insGAA, p.T148-T149in-sR) in KCNJ5 in a female patient and a novel mutation in ATP1A1 and ATP2B3, respectively.
What Is Relevant?
• KCNJ5 mutations were more prevalent in females, whereas ATPase mutations were males.
• KCNJ5 mutation carriers had larger adenomas, higher aldosterone production, and lower minimal serum K + level.
• T148-T149insR in KCNJ5 might influence membrane voltage and Ca 2+ homeostasis and increase CYP11B2 mRNA expression and aldosterone production.
Summary
Somatic KCNJ5 mutations have a distinctively high prevalence in sporadic aldosterone-producing adenomas in Chinese compared with ATP1A1, ATP2B3, and CACNA1D mutations. Patients with KCNJ5 mutations had distinguishable phenotypes. T148-T149insR in KCNJ5 might participate in the loss of K + channel selectivity and increase aldosterone synthesis.
Supplemental Methods
Subjects 168 patients with primary aldosteronism (PA) recruited between 2008 and 2014 in the Hypertension Department (Ruijin hospital, Shanghai Jiao Tong University School of Medicine) were analyzed retrospectively. The PA workup was carried out according to the guidelines of Endocrine Society ( Figure S1 ). 1, 2 In brief, patients from many provinces with the following profile or characteristic were attracted to our out-patient clinic for PA screening: hypertension and hypokalemia; hypertension and adrenal incidentaloma; resistant hypertension; etc. Before measuring plasma aldosterone concentration (PAC) and plasma rennin activity (PRA), mineralocorticoid receptor (MR) antagonists were withdrawn for at least 6 weeks, non-potassium sparing diuretics for 4 weeks, and β-blockers, angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor blockers (ARBs) for 2 weeks. In case of blood pressure control, non-dihydropyridine Ca 2+ blockers and/or α1-blockers were prescribed. Patients with aldosterone-renin-ratio (ARR) >24 (ng/dL)/(ng/mL/h) at least two times at out-patient clinic were PA candidates. Then they were hospitalized for confirmation test. Intravenous saline loading test was applied. Patients with post-test PAC>6 ng/dL were diagnosed to have PA in our unit. The patients underwent the thin-sliced adrenal computed tomography (CT) scanning. Adrenal venous sampling (AVS) was carried out in patients who were candidates and were also willing to receive the adrenalectomy. A selectivity index (SI, adrenal cortisol to peripheral cortisol) ≥3.0 and a lateralization index (LI, aldosterone/cortisol ratio from high to low side) ≥2.0 without cosyntropin stimulation were used in our clinic, which was in line with an expert consensus.
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The aldosterone-producing adenomas (APAs) were verified by histopathology.
DNA Isolation
DNA was extracted from 168 APAs, matched peritumoral adrenal tissue from 122 patients and matched peripheral venous blood from 90 patients. DNA was also extracted from 11 cortisol-producing adenomas, 10 adrenal pheochromocytomas and 26 nonfunctional adrenal adenomas in accordance with the protocol (TIANamp Genomic DNA Kit, TIANGEN, China).
Sanger sequencing of KCNJ5 and other genes
The partial sequences of KCNJ5, ATP1A1, ATP2B3 and CACNA1D were amplified using primers described previously. 4, 5 The PCR conditions were similarly as follows: 95ºC for 5 min; 35 cycles of 94ºC for 1 min, 60ºC for 1 min, 72ºC for 1 min; 72ºC for 10 min using a GeneAmp PCR system 9700 (Applied Biosystems). Sanger sequencing of the purified PCR products was performed on an Applied Biosystems 3730xl DNA Analyzer.
Evaluation of KCNJ5 protein expression in APAs by western blotting
The adrenal tissue from 50 APAs was lysed in tissue protein extraction buffer (Promoton). The lysate of adrenal tissue was quantified by the BCA method. Equal amounts of total protein were subjected to SDS-PAGE in a 10% gel for KCNJ5 immunoblotting and transferred to a polyvinylidene difluoride membrane (Millipore) by electroblotting. The membrane was blocked and incubated with anti-KCNJ5 (1:2000; Sigma) followed by horseradish peroxidase-conjugated secondary antibody (Santa Cruz). The immunoreactive bands were detected by enhanced chemiluminescence (GE healthcare) and quantified by Image J 1.44 (National Institutes of Health, Bethesda, MD). At 48 h after electroporation, total RNA was abstracted from NCI-H295R cells using TRIzol reagent (Invitrogen). 2 μg of total RNA was reverse transcribed into single-stranded cDNA by incubation with moloney murine leukemia virus reverse transcriptase (Promega). For quantification of CYP11B2 mRNA expression, real-time PCR was performed using the SYBR Premix Ex Taq kits (Takara) based on manufacturer's protocol in ABI PRISM 7900 system (Applied Biosystems). β-actin was used as standard reference. Reactions were done at 95ºC for 30 sec followed by 40 cycles of 95ºC for 5 sec, 60ºC for 30 sec in a total volume of 10 μL. The aldosterone concentration in the supernatant of H295R cells was measured by radioimmunoassay (Beckman Coulter) and normalized to total cell protein. The cells were lysed in cell protein extraction buffer (Promoton). The lysate was quantified by the BCA method.
Electrophysiological experiment of the T148-T149insR mutation in KCNJ5 in Human embryonic kidney 293T cells Human embryonic kidney (HEK) 293T cells were cultured in DMEM (Biowest) supplemented with 10% FBS (Gibco). KCNJ3 (1 μg) and either KCNJ5 WT (0.5 μg) or KCNJ5 T148-T149insR (0.5 μg) were transiently cotransfected in 293T cells in 35 mm dishes by X-tremeGENE HP DNA Transfection Reagent (Roche). Besides, empty vector was used as control. At 24 h after transfection, whole-cell voltage clamp recordings were performed on cotransfected cells (red and green fluorescence) using an EPC-10 amplifier (HEKA, Germany). The 293T cell was hold at 0 mV and clamped from -100 mV to 60 mV in 20 mV increments which was repeated at least 3 times. The solutions were followed as: external solution (140 mM NaCl, 5 mM KCl, 1.8 mM MgCl 2 , 1.8 mM CaCl 2 and 10 mM HEPES, pH=7.4) and pipette solution (140 mM KCl, 4 mM MgCl 2 , 1 mM CaCl 2 , 1 mM EGTA and 5 mM HEPES, pH 7.4). 6 Moreover, 1 mM BaCl 2 was added into the external solution to test the K + channel sensitivity to barium. ] i than KCNJ3/KCNJ5 WT (n=11) and empty vector (n=6). The data are presented as mean±SD and assessed by one-way ANOVA followed by post-hoc analysis. *P<0.01.
Intracellular Ca
